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Abstract
Dengue emerged as a public health burden in 
Southeast Asia during and following the Second 
World War and has become increasingly impor-
tant, with progressively longer and more frequent 
cyclical epidemics of dengue fever/dengue hem-
orrhagic fever. Despite this trend, surveillance for 
this vector-borne viral disease remains largely 
passive in most Southeast Asian countries, with-
out adequate laboratory support. We review here 
the factors that may have contributed to the 
changing epidemiology of dengue in Southeast 
Asia as well as challenges of disease prevention. 
We also discuss a regional approach to active 
dengue virus surveillance, focusing on urban 
areas where the viruses are maintained, which 
may be a solution to limited financial resources 
since most of the countries in the region have de-
veloping economies. A regional approach would 
also result in a greater likelihood of success in 
disease prevention since the large volume of hu-
man travel is a major factor contributing to the 
geographical spread of dengue viruses.
Dengue; Disease Prevention; Communicable Dis-
eases
Introduction
Dengue fever/dengue hemorrhagic fever is a re-
emerging disease that is endemic throughout the 
tropical world, with frequent and cyclical epi-
demics. The disease is caused by the dengue vi-
ruses, a Flavivirus that is transmitted principally 
by the Aedes aegypti mosquito. Other mosquito 
species such as Ae. albopictus and Ae. polynesien-
sis can also transmit epidemic dengue, but do so 
less efficiently 1,2. The virus has four antigenically 
similar but immunologically distinct serotypes. 
Thus a person can be infected with the dengue 
virus up to four different times. Furthermore, 
epidemiological observations suggest that a 
person’s risk of developing dengue hemorrhagic 
fever, characterized by increased plasma leakage 
as a result of alteration in microvascular perme-
ability 3, increases with subsequent infections 4. 
If not properly managed, the mortality of den-
gue hemorrhagic fever can be as high as 30% 5. 
There is as yet no specific treatment for dengue 
fever or dengue hemorrhagic fever although with 
proper clinical diagnosis and management, den-
gue hemorrhagic fever mortality rates are < 1%; 
efforts to develop anti-dengue drugs are in prog-
ress. Prevention of this disease is thus imperative. 
While vaccines for other flaviviruses such as yel-
low fever and Japanese encephalitis have been 
developed, dengue vaccine development is com-
plicated by the need to incorporate all four virus 
serotypes into a single formulation. An approved 
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vaccine is thus not likely to be available for five to 
ten years; the only way to prevent dengue trans-
mission, therefore, is to reduce the population of 
its principal vector, Ae. aegypti.
Dengue in Southeast Asia
Dengue emerged as a public health burden in 
Southeast Asia following the Second World War, 
which led to significant ecological disruption and 
demographic changes. The movement of equip-
ment and people during the war resulted in the 
transportation of Ae. aegypti to new geographic 
areas. The use of containers to store water for do-
mestic use and fire control following destruction 
of the then existing water systems, along with the 
presence of discarded war equipment and junk, 
all served as ideal breeding habitats for Ae. ae-
gypti. Together, these factors contributed to the 
expanded geographic distribution and popula-
tion densities of Ae. aegypti. The movement of 
Japanese and Allied troops in and out of the re-
gion also served to provide susceptible hosts for 
dengue virus 6.
Although the Second World War served to ex-
pand the geographic distribution of the dengue 
viruses and their vector, it was the urbanization 
of Southeast Asia after the war that provided 
the ideal conditions for virus propagation. Mil-
lions of people moved to the cities seeking work, 
resulting in hurried but unplanned growth of 
urban centers in many parts of Southeast Asia. 
Housing, water supply and sewerage systems 
were inadequate. This mixture of an ideal breed-
ing habitat for the highly domesticated Ae. ae-
gypti as well as susceptible human hosts resulted 
in epidemic dengue. 
It was thus in this setting that dengue 
emerged as a leading public health burden in 
Southeast Asia. Manila, Philippines recorded 
the first dengue hemorrhagic fever outbreak in 
1953/1954, with a second outbreak two years 
later in 1956 6. Bangkok had an epidemic in 1958 
although sporadic cases of dengue hemorrhagic 
fever were identified in Thailand throughout the 
1950s 7,8. The significance of dengue hemor-
rhagic fever as a public health burden may be 
appreciated from Halstead’s Alexander D. Lang-
muir lecture in 1981: “Dengue hemorrhagic fever 
is an important cause of morbidity and mortality 
predominantly, but not exclusively, in children 
in tropical Asia. Over half a million persons have 
been hospitalized with this syndrome in the past 
20 years, more than 200,000 in the past two years 
alone”  9 (p. 632-3).
The cyclical dengue epidemics in Southeast 
Asia that started in the 1950s have continued to 
the present time, with each epidemic being larg-
er in magnitude than before. Figure 1 shows the 
incidence of dengue fever/dengue hemorrhagic 
fever in Southeast Asian countries in this mil-
lennium, from 2000 to 2005, with data obtained 
from WHO’s DengueNet (http://www.who.int/
globalatlas). The data presented in this figure is 
likely to represent only a fraction of the total dis-
ease burden since some countries do not report 
dengue fever but only dengue hemorrhagic fe-
ver. Furthermore, since most countries rely on a 
passive surveillance system, infections resulting 
in less severe dengue disease or unusual clinical 
presentations 10,11 would likely have gone undi-
agnosed etiologically. Nonetheless, it is apparent 
that the trend in dengue activity will continue 
unabated well into the 21st Century. 
Current developments in Southeast Asia
The urbanization of Southeast Asia that started 
after World War II continues to this day. Figure 
2 shows data obtained from the United Nations’ 
World Urbanization Prospects: the 2005 Revi-
sion Population Database, where the increas-
ing trends observed since the 1950s in both the 
urban population size as well as the proportion 
of the total population living in urban areas are 
likely to continue for the next few decades 12. Not 
all of this population expansion is directly due to 
increases in birth rates. In Singapore, the popula-
tion is growing at a rate of 4.4% in 2007 (htt://
www.singstat.gov.sg/stats/keyind.html). Howev-
er, the total fertility rate per resident female is on-
ly 1.26. These indicate that population expansion 
is through the immigration of foreigners, many of 
whom would likely be from the developed world 
and are attracted to the thriving economy of this 
city state. Moreover, urban population growth in 
many Southeast Asian countries is due to rural 
people migrating to the cities for economic pur-
poses 12. This trend would result in further in-
creases to the population density of susceptible 
human hosts.
The impact of this population expansion 
and urbanization of Southeast Asia can be un-
derstood by studies carried out by Cummings 
et al. 13. They have suggested, using mathemati-
cal modeling, that dengue virus resides in and 
spreads out of Bangkok and other urban cen-
ters, to the rest of the region, moving at a speed 
of 148 kilometers per month. This spread oc-
curred in three-yearly waves of large outbreaks, 
each driven by a change in the predominant se-
rotype of dengue virus. Similarly, surveillance 
data suggested that the 1976-1977 epidemics of 
dengue hemorrhagic fever caused by DEN-3 in 
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Indonesia, began in Jakarta and spread out from 
that city 14,15. With further expansion of the ur-
ban populations, dengue activity will remain at 
a level favorable for the continuation of cyclical 
epidemic activity, with each cycle being larger in 
magnitude 12,13,15.
Mass air transport serves as an efficient 
means for transporting dengue virus between 
urban centers of the tropics. This activity has 
increased in Southeast Asia through increased 
trade and travel across the region. In 2006, Singa-
pore reported a total of 107,092 aircraft landings, 
with a combined total of over 35 million people 
passing through this airport alone, a figure that 
is nearly nine times the population of Singapore. 
The number of travelers passing through other 
major airports in Southeast Asia, such as those 
in Kuala Lumpur and Bangkok are also similar 
in numbers. 
While the population and urban centers have 
increased in size in Southeast Asia, the public 
health infrastructure has not been able to keep 
up with this pace in many countries. Increas-
ing numbers of people continue to live with in-
adequate access to good housing, clean water, 
sewage and waste management systems, thus 
increasing exposure to mosquito vectors that 
transmit dengue and other diseases 1,12. Access to 
vector control and disease prevention programs 
is even more limited although those places that 
have implemented community-based programs 
along with the use of both old and new vector 
control tools have had positive effects on pre-
venting disease transmission 16,17,18,19. It is likely 
that this lack of development in the public health 
infrastructure will continue to allow Ae. aegypti 
to thrive, increasing its geographical distribution 
and population densities.
Figure 1  
Annual incidence of dengue fever/dengue hemorrhagic fever in Southeast Asian countries, 2000-2005.
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How should Southeast Asia respond to 
dengue?
Dengue fever/dengue hemorrhagic fever surveil-
lance is an important component of any disease 
prevention and control program 20. The primary 
goal of public health surveillance is to monitor 
dengue transmission in a community to guide 
effective programs to prevent the occurrence and 
spread of the disease. Other goals for surveillance 
include defining disease severity, determining 
the cost-effectiveness of public health preven-
tion programs, and estimating the burden of 
disease in the community. The ideal surveillance 
program should thus be able to monitor dengue 
cases accurately, predict impending epidemics 
from a background of endemic disease and trig-
ger the necessary preventive measures. 
While it is clear that surveillance is the cor-
nerstone of dengue virus transmission preven-
tion, the literature suggests that much could yet 
be done to improve the sensitivity and speci-
ficity of most surveillance programs 20,21,22,23,24. 
Most Southeast Asian countries acknowledge 
the need for disease surveillance and emer-
gency response but few have the infrastructure 
and functional systems to support such a sys-
tem. Dengue virus transmission continues to 
be monitored by passive surveillance of dengue 
cases. Table 1 is an extract from a recent review 
of research needs for dengue surveillance and 
emergency response 23, which is an update of 
a review of surveillance systems in dengue-en-
demic countries by Gubler 24.  The table is a sub-
jective evaluation of the status and efficiency of 
the surveillance systems, and whether these are 
supported by laboratory capabilities with early 
warning predictive capabilities for epidemic 
transmission. It also attempts to capture wheth-
er countries report both dengue fever and den-
gue hemorrhagic fever or dengue hemorrhagic 
fever alone, based on data obtained from WHO’s 
DengueNet, a global real-time information ex-
change system for dengue-endemic countries 
to share surveillance data on a timely basis with 
each other and with the WHO. The findings in 
2006 23 are largely similar to those reported in 
2002 24.  With a few exceptions, most Southeast 
Asian countries do not have the systems in place 
for active, laboratory-based surveillance, and 
therefore, for effective emergency response, or 
effective prevention programs. Instead, there is 
over reliance on passive surveillance systems 
without uniformity in case definitions used. 
Moreover, most countries do not even enforce 
laws that make dengue a notifiable disease.
Figure 2  
Total population and percentage of population living in urban areas in Southeast Asia, including Timor Leste, from 1950 and 
projected to 2030. 
Source: data obtained from the United Nations’ World Urbanization Prospects: The 2005 Revision Population Database.
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Over reliance on passive surveillance systems
Passive surveillance relies on healthcare pro-
fessionals to notify public health authorities of 
all suspected or laboratory-confirmed dengue 
cases. However, passive surveillance systems are 
not suitable for monitoring dengue virus trans-
mission. Such a surveillance system is uniformly 
insensitive because of low index of suspicion for 
dengue, particularly during the inter-epidemic 
periods 21,25. Furthermore, dengue infection re-
sults in a spectrum of clinical outcomes: from 
completely asymptomatic, undifferentiated 
viral syndrome, dengue fever, dengue hemor-
rhagic fever, to dengue shock syndrome, and 
other severe manifestations such as neurotropic 
disease and hepatic failure 26. Passive surveil-
lance using dengue fever/dengue hemorrhagic 
fever case definitions alone lack specificity since 
many other infectious diseases that are either 
endemic or cause periodic epidemics in South-
east Asia, such as influenza, chikungunya fever, 
enterovirus infections, leptospirosis, malaria 
and typhoid fever all present with similar symp-
toms and signs as dengue in the acute phase of 
illness 26,27.
Another important consideration is that the 
use of passive surveillance alone also ignores 
the patients who present with undifferentiated 
febrile illness or viral syndrome.  This group of 
patients represents a large proportion of those 
with symptomatic dengue infection, depend-
ing on the age of the patient and the strain of 
infecting virus 28. Since it is difficult to differen-
tiate mild dengue from other causes of undif-
ferentiated fever clinically, it would be impos-
sible to carry out passive surveillance on such 
dengue cases. This may contribute to a signifi-
cant gap in our surveillance effort and possibly 
limit our epidemic prediction capability. Mild 
viral syndrome is of particular importance in 
monitoring dengue transmission during inter-
epidemic periods when classical dengue fever 
and dengue hemorrhagic fever incidence is 
low 1,20. In countries where dengue circulates 
hyperendemically, emergence of genetic vari-
ants with greater epidemic potential may be 
partially responsible for the cyclical outbreaks 
14,15,29  since certain viral clades appear to be 
more associated with increased transmission 
and severe disease outcomes 30,31,32,33. Virologic 
surveillance for cases that present with mild vi-
ral syndrome may yield such pre-epidemic iso-
lates for comparative analysis. Although more 
work will need to be done before such data can 
be used for epidemic prediction, the key to un-
derstanding dengue epidemiology lies in better 
virologic surveillance during the inter-epidemic 
periods 15,20,21.
Table 1  
Southeast Asian countries and their dengue fever/dengue hemorrhagic fever surveillance capabilities.
 Southeast Asian country Surveillance Lab capability Epidemic 
  Passive Active   prediction
  Dengue Dengue Dengue fever/ Serology Virology 
   hemorrhagic  dengue  
   fever hemorrhagic fever 
 Brunei + ++ - + + -
 Cambodia + ++ - ++ + * -
 Indonesia - +++ - + + * -
 Laos + + - - - -
 Malaysia ++ +++ + +++ +++ +
 Myanmar - ++ - + + -
 Philippines + + - ++ + -
 Singapore +++ +++ + +++ +++ +
 Thailand - +++ - ++ ++ * -
 Vietnam + +++ - ++ +++ -
The effi cacy of the surveillance system and laboratory capability is rated as follows:
(-) Surveillance or public health laboratory capability does not exist; (+) exists; (++) good; (+++) best.
* Does not include US Military, Centers for Disease Control and Prevention (CDC), Institute Pasteur or World Health Organiza-
tion (WHO) laboratories.
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Lack of uniformity in the case definitions used
The current surveillance for dengue in Southeast 
Asia also lacks uniformity in case definition. Dif-
ferent countries classify dengue fever/dengue 
hemorrhagic fever differently, and there is varia-
tion in the types of dengue cases that are includ-
ed in surveillance reports among countries that 
adopt different criteria for classifying dengue 
cases 23,24. Furthermore, some countries report 
only dengue hemorrhagic fever while others 
include dengue fever in their surveillance 23,24. 
Recently, however, the usefulness of the existing 
dengue classification scheme and case defini-
tions for dengue hemorrhagic fever according to 
the WHO guidelines has come under scrutiny 34 
although this issue first surfaced as far back as 
1983 35. Experiences from various parts of the 
world suggest that the usefulness of the case def-
inition is not universal 29,35,36,37. Perhaps more 
importantly, the WHO case definition underesti-
mates the severe dengue cases among adults 38. 
This is a problem that needs to be addressed 
since adult disease is not just confined to travel-
ers from developed countries. In Southeast Asia, 
dengue primarily affects the adult population in 
Singapore 39,40, while the average age of infec-
tion has been observed to be increasing in other 
places 41,42. Notwithstanding the current debate 
over the WHO case definition, there is also no 
consistency in the way these definitions are ap-
plied across dengue-endemic countries. All of 
these different practices contribute to the under-
estimation of the true extent of dengue transmis-
sion and limit the ability to compare surveillance 
data among countries and regions.
Implementing active dengue virus 
surveillance for Southeast Asia
Given the pivotal role dengue surveillance plays 
in disease prevention, it is apparent that passive 
surveillance alone will not generate sufficient in-
formation needed for outbreak prediction and 
the recommendation for an active surveillance 
system has been advocated by WHO and others 
since the 1980s 14,20,21,25,43,44. Virological surveil-
lance should be conducted on patients that pres-
ent with non-specific viral syndrome, classical 
dengue fever, with hemorrhagic or neurological 
manifestation and on all patients with a fatal 
outcome following viral prodrome 1,20,21,25. This 
approach, using sentinel physicians, clinics, and 
hospitals, would result in a more comprehensive 
surveillance for dengue virus transmission in the 
population. Yet, in Southeast Asia where dengue 
fever/dengue hemorrhagic fever epidemics are 
reported every three to six years, only Malaysia 
and Singapore have adequate laboratory capac-
ity (Table 1) 23. Most other countries continue to 
rely on passive case notification for dengue hem-
orrhagic fever alone. 
Possibly the fundamental reason why active 
surveillance is not widely implemented is likely 
to be the lack of financial resources. To establish 
an active, laboratory-based surveillance system, 
coupled with effective community-based, inte-
grated vector control requires both the necessary 
public funds and political will. Unfortunately, 
most dengue-endemic countries have develop-
ing economies and resources. Such funds are 
often directed to other highly visible public pro-
grams instead of disease prevention. This prob-
lem, however, could be overcome by focusing 
the surveillance effort on where epidemics are 
likely to emerge. The work by Cummings et al. 13 
has provided good data to support previous 
epidemiological observations that dengue epi-
demics emerge from urban environments and 
then spread to new areas 14,15. A focus on tropi-
cal urban areas could thus provide epidemic 
prediction and thus an early warning of dengue 
outbreaks despite limited resources. 
While the implementation of active surveil-
lance programs in urban centers of Southeast 
Asia would need to be carried out under the aus-
pices of the local health authorities, the overall 
effort needs to be coordinated at the regional lev-
el. This need is perhaps emphatically highlighted 
by Singapore’s near four decade experience with 
dengue surveillance and vector control 40. Den-
gue hemorrhagic fever appeared in Singapore in 
the 1960s and quickly became a major cause of 
childhood mortality. The public health response 
to dengue began in 1966 with a series of entomo-
logical and epidemiological surveys 45,46,47,48,49. 
Based on these studies, a surveillance-based 
vector control system was developed and im-
plemented in 1968 50. Its main element was to 
reduce Aedes larval habitats, or larval source re-
duction, backed with public education and law 
enforcement. The implementation of this vector 
control program was completed in 1973, after 
which Singapore experienced a 15-year period 
of low dengue incidence until the 1990s, when 
epidemic dengue fever re-emerged with five- to 
seven-yearly cycles. Multiple factors contribute 
to this resurgence of dengue in Singapore and 
these have been reviewed previously 40. One fac-
tor is likely to be the continued introduction of 
the virus from the Southeast Asian region through 
viremic travelers among the more than 35 million 
people that pass annually through Singapore’s 
airport. Singapore’s experience indicates that 
countries that attempt to prevent this viral dis-
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ease are doomed to failure due to re-importation 
of both virus and vector through a rising trend in 
regional and global travel. A coordinated regional 
approach to dengue prevention including active, 
laboratory-based surveillance is thus critical to 
success in Southeast Asia.
Several surveillance activities will benefit 
from such a regional coordination. One such ef-
fort is the establishment of a regional reference 
laboratory for dengue virus surveillance. Labora-
tory support is a critical component in surveil-
lance 1,20,21. In particular, the laboratory should 
be able to identify not only the presence of den-
gue virus, but also its serotype and correlate these 
to the severity of illness, and whether the patients 
are experiencing a primary or secondary dengue 
infection. Furthermore, information on the ge-
netic sequence of the circulating viruses, both 
during and between dengue epidemics, would 
be of great value to our eventual ability to pre-
dict epidemics. Such a regional laboratory would 
complement and expand the WHO’s DengueNet 
system, where morbidity and mortality data are 
shared among countries. 
Such work requires funding for infrastructure 
support and human resource capability develop-
ment. The countries that are more economically 
able to carry this load could and should take the 
lead in developing a surveillance network, espe-
cially since reducing virus transmission in the 
whole region is critical to reducing the incidence 
of dengue in the lead country itself.
Establishing a regional reference laboratory 
could also serve to standardize the laboratory 
methods used in surveillance, enabling the collec-
tion of data that can be compared among coun-
tries. Currently, many dengue-endemic countries 
lack laboratory support for dengue surveillance. 
Among those that do have laboratory support, 
there exists variation in laboratory methods used 
for virologic surveillance. This is especially true 
for molecular methods where the literature re-
ports a large number of real-time or end-point 
RT-PCRs for dengue virus. These assays vary 
in their sensitivity and specificity. Importantly, 
many of the new serological assays have not been 
properly validated and tested for cross-reactivity 
to other viruses, especially co-circulating flavivi-
ruses such as Japanese encephalitis, yellow fever 
and West Nile viruses. Standardization of the lab-
oratory methods used for virologic and serologic 
surveillance, along with the establishment of an 
international quality assurance program for such 
laboratories, would yield clear benefits.
Apart from standardizing the laboratory meth-
ods used for surveillance, it would also be neces-
sary for Southeast Asia to agree to harmonize the 
case definitions used for reporting dengue fever/
dengue hemorrhagic fever, which currently var-
ies from country to country. Furthermore, there 
is often a lack of denominator data, or the extent 
to which the cases that fit the clinical entities are 
sampled for dengue virus. This limits the abil-
ity to make quantitative assessment of dengue 
transmission and thus compare the effectiveness 
of various preventive measures when these are 
applied in different places. As previously recom-
mended 20,25, virologic surveillance should in-
clude patients that present with nonspecific viral 
syndrome, in addition to classical dengue fever, 
with hemorrhagic or neurologic manifestation 
and on all patients with a fatal outcome follow-
ing viral prodrome. This approach would result 
in a more comprehensive surveillance of dengue 
virus transmission in the population.
Data obtained from active surveillance also 
needs to be translated into public health pro-
grams to prevent virus transmission. In the ab-
sence of a vaccine, control of the vector popu-
lation density remains the only tool to achieve 
such a goal. Here, unlike virus surveillance, the 
approach to vector control would need to be tai-
lored to suit the cities, towns and suburbs in each 
of the Southeast Asian countries. While the prin-
ciple of reducing larval habitats may apply across 
the board, what works in one city or municipality 
may not be relevant to other places where the 
local ecology may be different. For example, Kay 
& Nam 16 and Nam et al. 17  reported remarkable 
success with vector and disease control with the 
use of copepods in water collecting barrels in 
Vietnam. Such an application would not be high-
ly relevant in urban Singapore or Kuala Lumpur 
where the universal availability of potable water 
to all households makes water storage for domes-
tic use unnecessary. Other examples abound 51,52  
and thus vector control programs would need to 
be relevant to the local ecology.
The clear need in entomological surveil-
lance, however, is an index or a measure of vec-
tor population density that may be predictive of 
epidemic dengue transmission 53. It was thought 
from Singapore’s experience in the 1970s that 
a premises index (the percentage of premises 
where Ae. aegypti larvae is found) of less than 5% 
was sufficient to prevent epidemic dengue 50. 
However, since the 1990s, it is obvious that in 
Singapore, dengue incidence has increased dra-
matically, despite an overall premises index of 
two per cent and below 40. This, however, may 
be due to the insensitive nature of a national 
premises index, where despite the low national 
index, there are places in Singapore where the 
Ae. aegypti population is high. Likewise, similar 
reports of limited ability to predict outbreaks 
have also been associated with the use of Bre-
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teau and container indices. A complicating fac-
tor is the role of herd immunity. Clearly, the vec-
tor population densities required for epidemic 
transmission are lower in regions with low herd 
immunity 54.
Other benefits of active surveillance and 
vector control
Active surveillance and vector control also have 
the benefit of early identification and prevention 
of yellow fever in Southeast Asia. The potential 
for epidemic urban yellow fever is high with the 
increased movement of people via modern trans-
portation 55. Urban yellow fever could move very 
quickly from the American tropics to Southeast 
Asia, where an estimated 1.8 billion people are 
at risk. It can be difficult to distinguish yellow fe-
ver from severe dengue clinically and antibodies 
developed against yellow fever cross react with 
the commonly used serology for dengue diagno-
sis. Active virologic surveillance, however, would 
rapidly detect the introduction of yellow fever or 
other exotic viral diseases. Unlike dengue, a safe 
and effective vaccine is available for yellow fever 
although to be effective, vaccination should be 
used for prevention, not in response to active sur-
veillance 55. Unfortunately, there is unlikely to be 
sufficient doses of yellow fever vaccine available 
for Southeast Asia. Thus public health investment 
in Ae. aegypti control would not only serve as ef-
fective preventive measure for epidemic dengue 
but also yellow fever and other diseases such as 
chikungunya in Asia.
Conclusion
The rising trend of dengue fever/dengue hem-
orrhagic fever incidence with frequent epidem-
ics will likely continue well into the 21st Century, 
resulting in significant economic and health 
impacts 56,57,58. The necessary infrastructure to 
reverse this trend is not in place in most dengue-
endemic countries. This is despite the availabili-
ty of tools to prevent such epidemics by control-
ling the principal vector, Ae. aegypti, as well as 
previous experiences from Cuba and Singapore, 
where dengue was successfully controlled, al-
though the effects were not sustainable in the 
long term given the large movement of people 
and trade material in the dengue-endemic re-
gion. To effectively prevent epidemic dengue fe-
ver/dengue hemorrhagic fever in the 21st Cen-
tury will require integrated regional approaches 
that include effective surveillance, emergency 
response, mosquito control, case management, 
and the effective use of both vaccines and anti-
viral drugs when they become available.
Resumo
A dengue emergiu como problema de saúde pública 
no Sudeste Asiático durante e após a Segunda Guer-
ra Mundial, e vem se agravando cada vez mais, com 
epidemias cíclicas progressivamente mais longas e 
freqüentes de dengue e de febre hemorrágica da den-
gue. Apesar dessa tendência, a vigilância dessa virose 
transmitida por vetores permanece basicamente pas-
siva na maioria dos países do Sudeste Asiático, sem 
apoio laboratorial adequado. O artigo apresenta uma 
revisão dos fatores que podem ter contribuído para a 
mudança no perfil epidemiológico da dengue na re-
gião, além de discutir os desafios para a prevenção da 
doença. Analisa-se também uma abordagem regional 
para a vigilância ativa dos vírus da dengue, focando 
as áreas urbanas onde eles se mantêm, o que pode re-
presentar uma solução à limitação de recursos finan-
ceiros, uma vez que a maioria dos países da região tem 
economias em desenvolvimento. Uma abordagem re-
gional também resultaria em maior probabilidade de 
sucesso na prevenção da doença, já que a grande cir-
culação de viajantes na região é um fator importante 
na disseminação dos vírus da dengue.
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